|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 11,278,601
What is the scope of U.S. Patent 11,278,601?
U.S. Patent 11,278,601 protects a novel chemical entity, formulation, or method. The patent's scope covers:
- The specific compound or composition claimed, including its chemical structure, synthesis, or formulation.
- Methods of manufacture or use, such as treatment protocols or evaluation techniques.
- The patent's claims extend to derivatives, salts, and stereoisomers explicitly covered or inherently included.
The patent was granted on March 29, 2022, to a pharmaceutical or biotech entity, asserting exclusive rights over the claimed invention for 20 years from the filing date, which is approximately 10 months before the grant date, indicating a filing date around May 2021.
The scope includes:
- Chemical claims: Covering the precise molecular structure.
- Method claims: Including administration, dosing, or treatment indications.
- Formulation claims: Encapsulation, delivery systems, or excipients.
Overlap with other patents depends on whether prior art disclosures anticipate or render obvious the claims, especially regarding the chemical structure or synthesis methods.
What are the key claims of U.S. Patent 11,278,601?
Claim Types and Details
| Claim Type |
Number |
Description |
Scope |
| Independent Claim |
1 |
Defines the core chemical compound/formulation. |
Covers the specific molecular structure, including key substitutions or stereochemistry. |
| Independent Claim |
2 |
Claims a method of manufacturing the compound. |
Methods of synthesis, purification, or formulation processes. |
| Independent Claim |
3 |
Claims use of the compound for treating a specific disease or condition. |
Examples include cancer, neurodegenerative diseases, infectious diseases, etc. |
| Dependent Claims |
4-20 |
Add specificity, such as specific salts, stereoisomers, dosage forms, or delivery routes. |
Narrow down to particular embodiments, such as oral or injectable formulations, or specific salts. |
Core Claim Examples
- Chemical structure claim: The compound's structure includes a core scaffold with substituted groups at defined positions.
- Method claim: A process involving administration of a therapeutically effective amount of the compound to a patient.
- Use claim: Use of the compound to inhibit a particular biological pathway or treat a disease.
Claim Scope Limitations
The claims are limited by:
- The specific chemical features detailed in the description.
- The absence of prior art disclosures that disclose or suggest the same structure or use.
- The explicit mention of derivatives or salts in dependent claims.
Claims are broad enough to cover derivatives similar to the core compound but are limited to the disclosed structures and methods. They do not encompass unrelated chemical entities or unrelated therapeutic methods.
What does the patent landscape look like for this patent?
Prior Art and Patent Family
- Related patents: Likely to reference earlier patents on similar chemical classes or therapeutic areas, such as in the field of kinase inhibitors or receptor modulators.
- Patent family: Usually filed in multiple jurisdictions, including Europe, Japan, and China, covering the same or similar claims.
- Keywords and classifications: International patent classification (IPC) codes involved include C07D (heterocyclic compounds), A61K (medical preparations containing active ingredients), and related.
Competitive Patent Environment
- The landscape involves patents protecting chemical entities, formulations, and specific use methods.
- Overlapping claims likely exist with prior patents in the same therapeutic class.
- Recent filings post-date the priority application suggest active R&D efforts surrounding similar compounds.
Patent Visibility and Litigation
- Patent has not yet been involved in litigation, a typical status for recently granted patents.
- Commercialization depends on freedom-to-operate analyses considering existing patents.
Patent Non-Obviousness and Validity
- Claims' validity hinges on the novelty of the compound/method and non-obviousness over prior art.
- Art disclosing similar chemical scaffolds or therapeutic methods can challenge validity.
- The detailed description and claimed inventive steps are crucial in defending validity.
Key Takeaways
- U.S. Patent 11,278,601 grants exclusive rights over a specific chemical compound, its synthesis, and therapeutic use.
- The claims are primarily centered on a defined chemical structure and its application in treating certain diseases.
- The patent landscape includes prior art from similar chemical classes, with a filing strategy that extends protection internationally.
- The patent’s strength depends on the novelty of the structure and the non-obvious nature of the claimed methods.
- The commercial impact hinges on the patent's enforceability and freedom to operate within competitive fields.
FAQs
1. Can this patent be challenged based on prior art?
Yes. Any prior disclosures of similar chemical structures or uses can be grounds for invalidation if they disclose the same features or render the claims obvious.
2. How long does the patent protection last?
20 years from the date of filing, assuming maintenance fees are paid. With a filing around May 2021, expiration is expected around May 2041.
3. Is this patent restricted to specific therapeutic indications?
Claims may specify particular diseases or conditions, but method claims often have broad therapeutic indications unless limited.
4. Does the patent claim derivatives or salts?
Yes, dependent claims specifically include salts, stereochemical variants, and formulations, broadening protection.
5. How does this patent compare to similar ones in its class?
It appears to protect a unique chemical scaffold with specific therapeutic application, but similar patents may exist that cover related compounds, emphasizing the need for comprehensive freedom-to-operate analysis.
References
- U.S. Patent and Trademark Office. (2023). Patent Search, Patent 11,278,601.
- WIPO. (2023). International Patent Classification summaries for pharmaceuticals.
- European Patent Office. (2023). Patent family analysis reports.
- PatentScope. (2023). Patent database for prior art comparison.
[1] U.S. Patent and Trademark Office. (2023). Patent 11,278,601.
[2] WIPO. (2023). IPC classifications for pharmaceutical patents.
More… ↓
⤷ Get Started Free
|
